These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30281512)

  • 1. The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus.
    Duff CJ; Solis-Trapala I; Driskell OJ; Holland D; Wright H; Waldron JL; Ford C; Scargill JJ; Tran M; Hanna FWF; Pemberton RJ; Heald A; Fryer AA
    Clin Chem Lab Med; 2018 Dec; 57(2):296-304. PubMed ID: 30281512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression model.
    Oke JL; Stevens RJ; Gaitskell K; Farmer AJ
    Diabet Med; 2012 Feb; 29(2):266-71. PubMed ID: 21838767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirically establishing blood glucose targets to achieve HbA1c goals.
    Wei N; Zheng H; Nathan DM
    Diabetes Care; 2014 Apr; 37(4):1048-51. PubMed ID: 24513588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.
    Lind M; Pivodic A; Cea-Soriano L; Nerman O; Pehrsson NG; Garcia-Rodriguez LA
    Diabetologia; 2014 Aug; 57(8):1586-94. PubMed ID: 24811709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study.
    Montvida O; Shaw JE; Blonde L; Paul SK
    Diabetes Obes Metab; 2018 Jul; 20(7):1722-1731. PubMed ID: 29536608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.
    Driskell OJ; Holland D; Waldron JL; Ford C; Scargill JJ; Heald A; Tran M; Hanna FW; Jones PW; Pemberton RJ; Fryer AA
    Diabetes Care; 2014 Oct; 37(10):2731-7. PubMed ID: 25249670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of type 2 diabetes monitoring in rural towns: How does frequency of HbA1c and lipid testing compare with existing guidelines?
    Paul CL; Piterman L; Shaw JE; Kirby C; Barker D; Robinson J; Forshaw KL; Sikaris KA; Bisquera A; Sanson-Fisher RW
    Aust J Rural Health; 2016 Dec; 24(6):371-377. PubMed ID: 27086673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in Test Interval Is Linked to Glycated Haemoglobin (HbA1c) Trajectory over Time.
    Fryer AA; Holland D; Stedman M; Duff CJ; Green L; Scargill J; Hanna FWF; Wu P; Pemberton RJ; Bloor C; Heald AH
    J Diabetes Res; 2022; 2022():7093707. PubMed ID: 35615258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
    Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
    Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both the frequency of HbA
    Schwandt A; Best F; Biester T; Grünerbel A; Kopp F; Krakow D; Laimer M; Wagner C; Holl RW;
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28544457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
    Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
    Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the new HbA1c units for the diagnosis of Type 2 diabetes.
    Braatvedt GD; Cundy T; Crooke M; Florkowski C; Mann JI; Lunt H; Jackson R; Orr-Walker B; Kenealy T; Drury PL
    N Z Med J; 2012 Sep; 125(1362):70-80. PubMed ID: 23178606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan-O randomized trial.
    Davies MJ; Rosenstock J; Ali A; Russell-Jones D; Souhami E; Palmer K; Ji C; Niemoeller E; Skolnik N
    Diabetes Obes Metab; 2022 Jan; 24(1):34-41. PubMed ID: 34617398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
    Hirst JA; Stevens RJ; Farmer AJ
    PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of prediction rules to target care intensification in veteran patients with diabetes.
    Campbell HM; Murata A; Charlton GA; Murata GH
    BMJ Health Care Inform; 2020 Jun; 27(1):. PubMed ID: 32546511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation?
    Mostafa SA; Davies MJ; Srinivasan BT; Carey ME; Webb D; Khunti K
    Postgrad Med J; 2010 Nov; 86(1021):656-62. PubMed ID: 20956395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
    Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
    Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.